Government subsidy on new drug development biased to Biotech.

Published: 2005-09-26 06:59:00

Updated: 2005-09-26 06:59:00

The government subsidy on the new drug development inclined more to the biotech areas. The government subsidy programs have also suspended on the total 10 subjects since 2003.

The MOHW report presented to the National Assembly described that the government supported 18,329 million won for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK